S-Nitrosothiol biology and therapeutic potential in metabolic disease

Current Opinion in Investigational Drugs

Volumn 11, Issue 10, 2010, Pages 1127-1134

  Kevil, C G ^a   Patel, R P ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Diabetes; nitric oxide; redox; signaling; thiol; vascular

Indexed keywords

NITRIC OXIDE; S NITROSOTHIOL; THIOL;

DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENZYME RELEASE; HUMAN; METABOLIC DISORDER; NITROSATION; NITROSYLATION; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT INDICATION;

DIABETES MELLITUS; HUMANS; METABOLIC DISEASES; NITRIC OXIDE; NITRIC OXIDE DONORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN S; S-NITROSOTHIOLS; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 77957570447     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Foster MW, Hess DT, Stamler JS: Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med (2009) 15(9):391-404.
2. Hogg N: Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med (2000) 28(10):1478-1486.
3. Hogg N: The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol (2002) 42:585-600.
4. Stamler JS, Toone EJ: The decomposition of thionitrites. Curr Opin Chem Biol (2002) 6(6):779-785.
5. Ding H, Triggle CR: Endothelial dysfunction in diabetes: Multiple targets for treatment. Pflugers Arch (2010) 459(6): 977-994.
6. Hink U, Tsilimingas N, Wendt M, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus: Therapeutic implications. Treat Endocrinol (2003) 2(5):293-304.
7. Lassegue B, Griendling KK: NADPH oxidases: Functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol (2010) 30(4):653-661.
8. Shelton J, Wang D, Gupta H, Wyss JM, Oparil S, White CR: The neointimal response to endovascular injury is increased in obese Zucker rats. Diabetes Obes Metab (2003) 5(6):415-423.
9. Wu G, Meininger CJ: Nitric oxide and vascular insulin resistance. Biofactors (2009) 35(1):21-27.
10. Blakytny R, Jude E: The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med (2006) 23(6): 594-608.
11. Li Y, Lee PI: Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. Mol Pharm (2010) 7(1):254-266.
12. Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ: Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes (2008) 57(3):696-705.
13. Elrod JW, Duranski MR, Langston W, Greer JJ, Tao L, Dugas TR, Kevil CG, Champion HC, Lefer DJ: eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: A role for eNOS uncoupling. Circ Res (2006) 99(1):78-85.
14. Pereira EC, Ferderbar S, Bertolami MC, Faludi AA, Monte O, Xavier HT, Pereira TV, Abdalla DS: Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus. Clin Biochem (2008) 41(18):1454-1460.
15. Ahanchi SS, Varu VN, Tsihlis ND, Martinez J, Pearce CG, Kapadia MR, Jiang Q, Saavedra JE, Keefer LK, Hrabie JA, Kibbe MR: Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome. Am J Physiol Heart Circ Physiol (2008) 295(6):H2388-H2398.
16. Konorev EA, Kalyanaraman B, Hogg N: Modification of creatine kinase by S-nitrosothiols: S-nitrosation vs. S-thiolation. Free Radic Biol Med (2000) 28(11):1671-1678.
17. Zhang Y, Hogg N: S-Nitrosothiols: Cellular formation and transport. Free Radic Biol Med (2005) 38(7):831-838.
18. Foster MW, McMahon TJ, Stamler JS: S-nitrosylation in health and disease. Trends Mol Med (2003) 9(4):160-168.
19. Sexton DJ, Muruganandam A, McKenney DJ, Mutus B: Visible light photochemical release of nitric oxide from S-nitroso-glutathione: Potential photochemotherapeutic applications. Photochem Photobiol (1994) 59(4):463-467.
20. Singh RJ, Hogg N, Joseph J, Kalyanaraman B: Photosensitized decomposition of S-nitrosothiols and 2-methyl-2-nitrosopropane. Possible use for site-directed nitric oxide production. FEBS Lett (1995) 360(1):47-51.
21. Singh RJ, Hogg N, Joseph J, Kalyanaraman B: Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem (1996) 271(31):18596-18603.
22. Gorren AC, Schrammel A, Schmidt K, Mayer B: Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. Arch Biochem Biophys (1996) 330(2):219-228.
23. Forrester MT, Foster MW, Stamler JS: Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J Biol Chem (2007) 282(19):13977-13983.
24. Marley R, Feelisch M, Holt S, Moore K: A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic Res (2000) 32(1):1-9.
25. Cha W, Lee Y, Oh BK, Meyerhoff ME: Direct detection of S-nitrosothiols using planar amperometric nitric oxide sensor modified with polymeric films containing catalytic copper species. Anal Chem (2005) 77(11):3516-3524.
26. 2-mediated nitric oxide release from S-nitrosoglutathione - Role of glutamate. Arch Biochem Biophys (1999) 372(1):8-15.
27. Riccio DA, Dobmeier KP, Hetrick EM, Privett BJ, Paul HS, Schoenfisch MH: Nitric oxide-releasing S-nitrosothiol-modified xerogels. Biomaterials (2009) 30(27):4494-4502.
28. Bindoli A, Fukuto JM, Forman HJ: Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid Redox Signal (2008) 10(9):1549-1564.
29. Cooper CE, Patel RP, Brookes PS, Darley-Usmar VM: Nanotransducers in cellular redox signaling: Modification of thiols by reactive oxygen and nitrogen species. Trends Biochem Sci (2002) 27(10):489-492.
30. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A: Redox-based regulation of signal transduction: Principles, pitfalls, and promises. Free Radic Biol Med (2008) 45(1):1-17.
31. Landar A, Darley-Usmar VM: Nitric oxide and cell signaling: Modulation of redox tone and protein modification. Amino Acids (2003) 25(3-4):313-321.
32. Poole LB, Nelson KJ: Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol (2008) 12(1): 18-24.
33. Rhee SG, Chae HZ, Kim K: Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med (2005) 38(12):1543-1552.
34. Benhar M, Forrester MT, Stamler JS: Protein denitrosylation: Enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol (2009) 10(10):721-732.
35. Akaike T: Mechanisms of biological S-nitrosation and its measurement. Free Radic Res (2000) 33(5):461-469.
36. Inoue K, Akaike T, Miyamoto Y, Okamoto T, Sawa T, Otagiri M, Suzuki S, Yoshimura T, Maeda H: Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem (1999) 274(38):27069-27075.
37. Basu S, Keszler A, Azarova NA, Nwanze N, Perlegas A, Shiva S, Broniowska KA, Hogg N, Kim-Shapiro DB: A novel role for cytochrome C: Efficient catalysis of S-nitrosothiol formation. Free Radic Biol Med (2010) 48(2):255-263.
38. Bosworth CA, Toledo JC Jr, Zmijewski JW, Li Q, Lancaster JR Jr: Dinitrosyliron complexes and the mechanism(s) of cellular protein nitrosothiol formation from nitric oxide. Proc Natl Acad Sci USA (2009) 106(12):4671-4676.
39. Feelisch M, Rassaf T, Mnaimneh S, Singh N, Bryan NS, Jourd'Heuil D, Kelm M: Concomitant S-, N-, and heme-nitros(yl) ation in biological tissues and fluids: Implications for the fate of NO in vivo. FASEB J (2002) 16(13):1775-1785.
40. Ckless K, van der Vliet A, Janssen-Heininger Y: Oxidative-nitrosative stress and post-translational protein modifications: Implications to lung structure-function relations. Arginase modulates NF-κB activity via a nitric oxide-dependent mechanism. Am J Respir Cell Mol Biol (2007) 36(6):645-653.
41. Crawford JH, Chacko BK, Pruitt HM, Piknova B, Hogg N, Patel RP: Transduction of NO-bioactivity by the red blood cell in sepsis: Novel mechanisms of vasodilation during acute inflammatory disease. Blood (2004) 104(5):1375-1382.
42. Eiserich JP, Patel RP, O'Donnell VB: Pathophysiology of nitric oxide and related species: Free radical reactions and modification of biomolecules. Mol Aspects Med (1998) 19(4-5):221-357.
43. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS, Steverding D: Nitrosative stress: Protection by glutathione-dependent formaldehyde dehydrogenase. Redox Rep (2001) 6(4):209-210.
44. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G, McMahon TJ, Dickfeld T, Marshall HE, Que LG, Stamler JS: Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell (2004) 116(4):617-628.
45. Arnelle DR, Stamler JS: NO+, NO, and NO- donation by S-nitrosothiols: Implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys (1995) 318(2):279-285.
46. Liu Z, Rudd MA, Freedman JE, Loscalzo J: S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther (1998) 284(2): 526-534.
47. Rossi R, Lusini L, Giannerini F, Giustarini D, Lungarella G, Di Simplicio P: A method to study kinetics of transnitrosation with nitrosoglutathione: Reactions with hemoglobin and other thiols. Anal Biochem (1997) 254(2):215-220.
48. Benhar M, Forrester MT, Hess DT, Stamler JS: Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science (2008) 320(5879):1050-1054.
49. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS: A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature (2001) 410(6827):490-494.
50. Mitchell DA, Marletta MA: Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol (2005) 1(3):154-158.
51. Sanghani PC, Davis WI, Fears SL, Green SL, Zhai L, Tang Y, Martin E, Bryan NS, Sanghani SP: Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase. J Biol Chem (2009) 284(36):24354-24362.
52. 2-adrenergic receptor gene-gene interaction: Bronchodilator responsiveness to albuterol. Pharmacogenet Genomics (2010) 20(6):351-358.
53. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, Stamler JS: Protection from experimental asthma by an endogenous bronchodilator. Science (2005) 308(5728): 1618-1621.
54. Lima B, Lam GK, Xie L, Diesen DL, Villamizar N, Nienaber J, Messina E, Bowles D, Kontos CD, Hare JM, Stamler JS et al: Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci USA (2009) 106(15):6297-6302.
55. Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L: S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med (2010) 2(19):19ra13.
56. Bateman RL, Rauh D, Tavshanjian B, Shokat KM: Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem (2008) 283(51):35756-35762.
57. Kaneki M, Shimizu N, Yamada D, Chang K: Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal (2007) 9(3):319-329.
58. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, Velloso LA, Curi R, Saad MJ: S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance. Diabetes (2005) 54(4):959-967.
59. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M: S-Nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem (2005) 280(9):7511-7518.
60. Carvalho-Filho MA, Ropelle ER, Pauli RJ, Cintra DE, Tsukumo DM, Silveira LR, Curi R, Carvalheira JB, Velloso LA, Saad MJ: Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRβ/IRS-1 and Akt. Diabetologia (2009) 52(11):2425-2434.
61. Pauli JR, Ropelle ER, Cintra DE, Carvalho-Filho MA, Moraes JC, De Souza CT, Velloso LA, Carvalheira JB, Saad MJ: Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats. J Physiol (2008) 586(2):659-671.
62. Cordes CM, Bennett RG, Siford GL, Hamel FG: Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem Pharmacol (2009) 77(6):1064-1073.
63. McGrowder D, Ragoobirsingh D, Brown P: Modulation of glucose uptake in adipose tissue by nitric oxide-generating compounds. J Biosci (2006) 31(3):347-354.
64. McGrowder D, Ragoobirsingh D, Brown P: Acute effects of exogenous nitric oxide on glucose uptake in skeletal muscle of normoglycaemic and diabetic rats. Med Sci Monit (2006) 12(1):BR28-35.
65. Ding SY, Tribble ND, Kraft CA, Markwardt M, Gloyn AL, Rizzo MA: Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation. Mol Endocrinol (2010) 24(1):171-177.
66. Tong X, Ying J, Pimentel DR, Trucillo M, Adachi T, Cohen RA: High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration. J Mol Cell Cardiol (2008) 44(2):361-369.
67. Wadham C, Parker A, Wang L, Xia P: High glucose attenuates protein S-nitrosylation in endothelial cells: Role of oxidative stress. Diabetes (2007) 56(11):2715-2721.
68. Angelo M, Singel DJ, Stamler JS: An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci USA (2006) 103(22):8366-8371.
69. Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M: Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol (2005) 1(5):290-297.
70. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT et al: Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 115(5):1232-1240.
71. Moya MP, Gow AJ, Califf RM, Goldberg RN, Stamler JS: Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet (2002) 360(9327): 141-143.
72. Kumar D, Branch BG, Pattillo CB, Hood J, Thoma S, Simpson S, Illum S, Arora N, Chidlow JH Jr, Langston W, Teng X et al: Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci USA (2008) 105(21):7540-7545.
73. Prime TA, Blaikie FH, Evans C, Nadtochiy SM, James AM, Dahm CC, Vitturi DA, Patel RP, Hiley CR, Abakumova I, Requejo R et al: A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci USA (2009) 106(26):10764-10769.
74. Chouchani ET, Hurd TR, Nadtochiy SM, Brookes PS, Fearnley IM, Lilley KS, Smith RA, Murphy MP: Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): Implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J (2010) 430(1):49-59.
75. Nadtochiy SM, Burwell LS, Brookes PS: Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J Mol Cell Cardiol (2007) 42(4):812-825.
76. Nadtochiy SM, Burwell LS, Ingraham CA, Spencer CM, Friedman AE, Pinkert CA, Brookes PS: In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. J Mol Cell Cardiol (2009) 46(6):960-968.
77. Broniowska KA, Zhang Y, Hogg N: Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols. J Biol Chem (2006) 281(45):33835-33841.
78. Hogg N, Broniowska KA, Novalija J, Kettenhofen NJ, Novalija E: Role of S-nitrosothiol transport in the cardioprotective effects of S-nitrosocysteine in rat hearts. Free Radic Biol Med (2007) 43(7):1086-1094.
79. Zhang Y, Hogg N: The mechanism of transmembrane S-nitrosothiol transport. Proc Natl Acad Sci USA (2004) 101(21):7891-7896.
80. Langford EJ, Brown AS, Wainwright RJ, de Belder AJ, Thomas MR, Smith RE, Radomski MW, Martin JF, Moncada S: Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet (1994) 344(8935):1458-1460.
81. Zafar MU, Vilahur G, Choi BG, Ibanez B, Viles-Gonzalez JF, Salas E, Badimon JJ: A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects. J Thromb Haemost (2007) 5(6):1195-1200.
82. Bohl KS, West JL: Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials (2000) 21(22):2273-2278.
83. Masters KS, Lipke EA, Rice EE, Liel MS, Myler HA, Zygourakis C, Tulis DA, West JL: Nitric oxide-generating hydrogels inhibit neointima formation. J Biomater Sci Polym Ed (2005) 16(5): 659-672.
84. Seabra AB, da Silva R, de Oliveira MG: Polynitrosated polyesters: Preparation, characterization, and potential use for topical nitric oxide release. Biomacromolecules (2005) 6(5):2512-2520.
85. Lipke EA, West JL: Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. Acta Biomater (2005) 1(6):597-606.
86. Amadeu TP, Seabra AB, de Oliveira MG, Costa AM: S-Nitrosoglutathione- containing hydrogel accelerates rat cutaneous wound repair. J Eur Acad Dermatol Venereol (2007) 21(5):629-637.
87. Johnson TA, Stasko NA, Matthews JL, Cascio WE, Holmuhamedov EL, Johnson CB, Schoenfisch MH: Reduced ischemia/reperfusion injury via glutathione- initiated nitric oxide-releasing dendrimers. Nitric Oxide (2010) 22(1):30-36.
88. Seabra AB, da Silva R, de Souza GF, de Oliveira MG: Antithrombogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces. Artif Organs (2008) 32(4):262-267.